Utility of plasma tumour necrosis factor-α and transforming growth factor-β1 as predictors of survival and treatment outcome in advanced non-small cell lung carcinoma

被引：9
|
作者：
Kumar, Sachin [1 ]
Guleria, Randeep [1 ]
Mohan, Anant [1 ]
Singh, Vikas [1 ]
Ali, Ashraf [1 ]
Bharti, Alok C. [2 ]
Das, Bhudev C. [3 ]
机构：
[1] All India Inst Med Sci, Dept Med, New Delhi 110029, India
[2] Inst Cytol & Prevent Oncol, Div Mol Oncol, Noida, Uttar Pradesh, India
[3] Univ Delhi, Dr BR Ambedkar Ctr Biomed Res, Delhi 110007, India
来源：
BIOMARKERS | 2010年 / 15卷 / 05期
关键词：
Chemotherapy; diagnosis; prognosis; response; GROWTH-FACTOR; TNF-ALPHA; SERUM-LEVELS; CANCER-TREATMENT; PHASE-II; LINES; CYTOKINES; INTERFERON; EXPRESSION; THERAPY;
D O I：
10.3109/1354750X.2010.485699
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
We hypothesized that plasma level of tumour necrosis factor (TNF)-alpha and transforming growth factor (TGF)-beta 1 may be a potential tool for diagnosis, prognosis and prediction of treatment outcome in non-small cell lung carcinoma (NSCLC). Plasma levels of TNF-alpha and TGF-beta 1 were quantified in 100 NSCLC patients and 100 controls. Association of TNF-alpha and TGF-beta 1 with response to therapy and survival was determined in 42 patients. An increased presence of TNF-alpha and TGF-beta 1 was observed in NSCLC compared with controls. TNF-alpha and TGF-beta 1 levels did not correlate with survival and response to chemotherapy. TNF-alpha and TGF-beta 1 do not appear to be reliable markers for predicting survival and response to therapy in advanced NSCLC.
引用
收藏
页码：446 / 453
页数：8
相关论文
共 50 条
  • [1] Tumour necrosis factor- α and transforming growth factor- β are significantly associated with better prognosis in non-small cell lung carcinoma: putative relation with BCL-2-mediated neovascularization
    L Boldrini
    A Calcinai
    E Samaritani
    F Pistolesi
    A Mussi
    M Lucchi
    C A Angeletti
    F Basolo
    G Fontanini
    British Journal of Cancer, 2000, 83 : 480 - 486
  • [2] Tumour necrosis factor-α and transforming growth factor-β are significantly associated with better prognosis in non-small cell lung carcinoma: putative relation with BCL-2-mediated neovascularization
    Boldrini, L.
    Calcinai, A.
    Samaritani, E.
    Pistolesi, F.
    Mussi, A.
    Lucchi, M.
    Angeletti, C. A.
    Basolo, F.
    Fontanini, G.
    BRITISH JOURNAL OF CANCER, 2000, 83 (04) : 480 - 486
  • [3] Nimotuzumab enhances the sensitivity of non-small cell lung cancer cells to tumor necrosis factor- by inhibiting the nuclear factor-κB signaling pathway
    Zhu, Jing
    Xin, Ying
    Liu, Xiaoliang
    Wang, Ying
    Liu, Ying
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2018, 15 (04) : 3345 - 3351
  • [4] Synergistic induction of apoptosis in human endothelial cells by tumour necrosis factor-α and transforming growth factor-β
    Emmanuel, C
    Foo, E
    Medbury, HJ
    Matthews, J
    Comis, A
    Zoellner, H
    CYTOKINE, 2002, 18 (05) : 237 - 241
  • [5] TRANSFORMING GROWTH FACTOR-β1 AND TUMOR NECROSIS FACTOR-α CONCENTRATION IN SERUM DURING DISTURBED LYMPH FLOW FROM A LIVER IN RATS
    Beck, B.
    JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2017, 68 (01): : 91 - 98
  • [6] Activin-A, Growth Differentiation Factor-11 and Transforming Growth Factor-β as predictive biomarkers for platinum chemotherapy in advanced non-small cell lung cancer
    Lim, Jennifer
    Murphy, Alexander
    Wong, Stephen
    Nagrial, Adnan
    Karikios, Deme
    Daneshvar, Dariush
    Mccloy, Rachael
    Steinmann, Angela M.
    O'Toole, Sandra
    Chin, Venessa
    CANCER TREATMENT AND RESEARCH COMMUNICATIONS, 2022, 32
  • [7] Regulation of human lung fibroblast C1q-receptors by transforming growth factor-β and tumor necrosis factor-α
    Lurton, J
    Soto, H
    Narayanan, AS
    Raghu, G
    EXPERIMENTAL LUNG RESEARCH, 1999, 25 (02) : 151 - 164
  • [8] Changes of Circulating Transforming Growth Factor-β1 Level During Radiation Therapy Are Correlated with the Prognosis of Locally Advanced Non-small Cell Lung Cancer
    Zhao, Lujun
    Ji, Wei
    Zhang, Li
    Ou, Guangfei
    Feng, Qinfu
    Zhou, Zongmei
    Lei, Mingfang
    Yang, Weizhi
    Wang, Luhua
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (04) : 521 - 525
  • [9] Genetic variations in the transforming growth factor-beta pathway as predictors of survival in advanced non-small cell lung cancer
    Lin, Moubin
    Stewart, David J.
    Spitz, Margaret R.
    Hildebrandt, Michelle A. T.
    Lu, Charles
    Lin, Jie
    Gu, Jian
    Huang, Maosheng
    Lippman, Scott M.
    Wu, Xifeng
    CARCINOGENESIS, 2011, 32 (07) : 1050 - 1056
  • [10] Plasma transforming growth factor-β1 level before radiotherapy correlates with long term outcome of patients with lung carcinoma
    Kong, FM
    Jirtle, RL
    Huang, DH
    Clough, RW
    Anscher, MS
    CANCER, 1999, 86 (09) : 1712 - 1719
12345